Author: therawinformant

  • Afterpay share price on watch after upgrading FY 2020 guidance

    afterpay share price

    afterpay share priceafterpay share price

    The Afterpay Ltd (ASX: APT) share price will be on watch on Thursday following a surprise after-market update on its FY 2020 performance.

    What did Afterpay announce?

    This afternoon the payments company revealed that its unaudited FY 2020 Net Transaction Loss (NTL) as a percentage of underlying sales is going to be better than previously expected.

    On 7 July 2020, the company released an update which advised that its NTL as a percentage of underlying sales was expected to be up to 55 basis points in FY 2020.

    However, the company now expects to report an NTL of just 0.38% for the financial year.

    Management advised that this improvement is primarily due to higher than anticipated collections of instalment payments relating to its 30 June 2020 receivables balance that have occurred since then.

    This has translated into a materially lower provision and lower losses than previously expected.

    Earnings guidance lifted.

    In light of this positive change in NTL, Afterpay’s unaudited FY 2020 Net Transaction Margin (NTM) as a percentage of underlying sales and its EBITDA (excluding significant items) are expected to be higher than previously thought.

    Management expects its NTM to be at approximately 2.25% and its EBITDA (excluding significant items) to be approximately $44 million. This compares very favourably to its previous NTM guidance of 2% and EBITDA guidance of $20 million to $25 million.

    In respect to its provisions, Afterpay’s unaudited provision for expected losses is expected to be approximately $34 million. This is based on an unaudited gross consumer receivables balance of approximately $817 million.

    Management explained: “The July Trading Update for the FY20 NTL% was based on a relatively short period of collections data relating to the 30 June 2020 receivables balance from 1 July 2020 through to the date of the 7 July 2020 announcement. Since that time, and with the benefit of more collections data reviewed as part of the process of preparing the full year financial statements, a reduced NTL% is now expected.”

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Afterpay share price on watch after upgrading FY 2020 guidance appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2YeLvxi

  • The smartest 7 ASX shares to buy if you have $2,000

    blackboard drawing of hand pointing to the words buy now

    blackboard drawing of hand pointing to the words buy nowblackboard drawing of hand pointing to the words buy now

    If you have $2,000 to invest then I think there are a number of smart ASX shares that you could buy.

    The share market has recovered strongly from the COVID-19 crash, but I think there are several ASX shares that would still make great buys today:

    Citadel Group Ltd (ASX: CGL)

    Citadel is an ASX tech share that provides software to essential sectors like defence, education and healthcare. I think its earnings are fairly defensive with the high-quality clients it works with. A large amount of its revenue comes from government-related entities.

    One of the main reasons why I think Citadel looks like a good buy is that it’s trading cheaply. At the current Citadel share price it’s trading at 13x FY22’s estimated earnings.

    I’m also excited by the UK healthcare software acquisition called Wellbeing. It increases Citadel’s recurring revenue and earnings before interest, tax, depreciation and amortisation (EBITDA) margin. Plus, it will allow management to help sell Citadel’s software into the UK market and sell the Wellbeing software into Australia. The combined package can be sold into other markets.

    Pushpay Holdings Ltd (ASX: PPH)

    Pushpay is an electronic donation business. Its main client base is the medium and large church sector in the US. Management think this is a big opportunity for the ASX share, which is why the company has a long-term target of US$1 billion of annual revenue.

    I was very impressed by the scalability of Pushpay in FY20. It increased its gross margin from 60% to 65% in just one year. In FY21 the ASX share is hoping to double its earnings before interest, tax, depreciation, amortisation and foreign currency (EBITDAF) to US$50 million to US$54 million.

    Church donations could prove to be a pretty defensive source of earnings for Pushpay in my opinion. I think it could become even more profitable as it grows larger. The current pandemic circumstances are very unfortunate, but they’re helping bring forward adoption of Pushpay.

    At the current Pushpay share price it’s trading at 33x FY22’s estimated earnings.

    Bubs Australia Ltd (ASX: BUB)

    Bubs is an infant formula business with plenty of growth potential. It’s growing strongly overseas with Asian consumers rapidly taking up its goat milk formula. In the fourth quarter of FY20 Bubs said Chinese direct sales increased by 26% and other export market sales rose by 71%. Vietnam is one market that Bubs is finding good early traction in.

    The company is reporting steady growth of its gross profit margin which could go even higher because its infant formula has a much higher gross margin than its other products. Higher margins is good for the bottom line. Bubs has good control over its supply chain through acquisitions with access to the largest goat herd in Australia. It also owns its own Chinese-approved manufacturing facility.

    At the current Bubs share price of $0.92 I think it has a lot of growth potential over the next five years.

    City Chic Collective Ltd (ASX: CCX)

    City Chic is one of the few ASX retail shares I’d be willing to buy. It’s a plus-size women’s fashion retailer of clothes, footwear and accessories.

    The company is doing incredibly well at increasing its sales and distribution network in the northern hemisphere. It’s working with both US and European partners to sell products. The core business is going well, even through the pandemic, thanks to a high level of online sales. City Chic was positioned well coming into this difficult period.

    I’m particularly excited by the ASX share’s strategy of buying financially-distressed competitors in the US. City Chic can turn them into online-only offerings which decreases costs substantially. It should lead to the company steadily building market share in the US.

    City Chic is currently trading at 24x FY22’s estimated earnings.

    MFF Capital Investments Ltd (ASX: MFF)

    I think that MFF Capital is one of the best listed investment companies (LICs) on the ASX. It’s very capably run by Chris Mackay. He has led the LIC to total shareholder returns of 18.1% per annum over the past decade. That’s a great run.

    This investment choice is a bet on Mr Mackay continuing the strong run over the next decade. MFF Capital has moved to a large cash position which means the ASX share is well placed to weather any market downturn later this year – it also gives lots of financial ammunition for MFF Capital to buy beaten-up shares at lower prices.

    MFF Capital recently announced it intends to keep increasing its dividend. Its two biggest share holdings are currently Visa and Mastercard – two quality businesses.

    BetaShares Global Quality Leaders ETF (ASX: QLTY)

    I think that it’s quality businesses that are best suited to get through whatever comes next. Businesses that can keep growing, despite COVID-19, are attractive propositions.

    This exchanged-traded fund (ETF) is invested in shares that rate well on four metrics: return on equity (ROE), debt to capital, cash flow generation ability and earnings stability.

    The businesses that feature at the top of this ETF’s holdings are indeed quality. It owns names like Nike, Intuit, Intuitive Surgical, Nvidia, Apple, Accenture and Adobe. These aren’t ASX shares, these are some of the best businesses in the world.

    It has performed well since inception in November 2018 with net returns of around 19% per year. Past performance isn’t a guarantee of future performance, but I think these quality names can keep on producing for the long-term.

    Vitalharvest Freehold Trust (ASX: VTH)

    Vitalharvest is an agricultural real estate investment trust (REIT). It owns berry and citrus fruit farms.

    The REIT generates both fixed rent and variable rent in the form of a profit share from its main tenant.

    At the current Vitalharvest share price, the ASX share is trading at a 19% discount to the net asset value (NAV) at 31 December 2019. This is a large discount, assuming the NAV hasn’t changed negatively. The NAV may even have risen.

    There is a new manager of Vitalharvest which is looking to target more acquisitions across the food logistics process with potential buys relating to food processing and storage.

    As a bonus, Vitalharvest offers a distribution yield of 6.2%.

    Foolish takeaway

    I think each of these ASX shares has the potential to beat the overall ASX over the next 12 months and the longer-term. At the current prices I’d probably go for Citadel first, along with Pushpay and Bubs. I think those smaller businesses have a lot of long-term growth potential.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Tristan Harrison owns shares of Magellan Flagship Fund Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of BUBS AUST FPO and PUSHPAY FPO NZX. The Motley Fool Australia has recommended BUBS AUST FPO, Citadel Group Ltd, and PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post The smartest 7 ASX shares to buy if you have $2,000 appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3iZGsJb

  • ASX 200 rises 0.7%, CSL soars 6.4%

    ASX 200

    ASX 200ASX 200

    The S&P/ASX 200 Index (ASX: XJO) went up by 0.72% to 6,168 points today.

    It was a very busy do for reporting today. Here were a number of the highlights:

    CSL Limited (ASX: CSL)

    The CSL share price went up 6.4%.

    In FY20 the large healthcare business saw statutory profit after tax grow by 17% in constant currency terms to US$2.1 billion with revenue growth of 9% in constant currency terms.

    The ASX 200 share declared a final dividend of US$1.07 per share, bringing the total full year dividend to US$2.02 – up 9%. In Australian dollar terms the dividend rose 11% to $2.95.

    Net profit after tax in FY21 is expected to be in the range of US$2.1 billion to US$2.265 billion in constant currency terms. That would be profit growth of up to 8%.

    WiseTech Global Ltd (ASX: WTC)

    The strongest performer within the ASX 200 was the WiseTech share price which rocketed higher by 34%.

    WiseTech reported that its total revenue increased by 23% to $429.4 million with the percentage of recurring revenue improving to 89%.

    Earnings before interest, tax, depreciation and amortisation (EBITDA) increased by 17% to $126.7 million. The EBITDA margin declined slightly to 30%.

    Net profit attributable to shareholders rose by 197% to $160.8 million. However, underlying net profit was flat at $52.6 million.

    WiseTech declared a final dividend per share of $1.60, down 18% from last year’s $1.95 per share payment.

    In FY21 the ASX 200 company is predicting that revenue will be between $470 million to $510 million, representing growth of 9% to 19%. EBITDA is expected to grow to $155 million to $180 million, which would be growth of 22% to 42%.

    Corporate Travel Management Ltd (ASX: CTD)

    The Corporate Travel Management share price rose by more than 10% after releasing its FY20 result.

    The ASX 200 business reported underlying EBITDA of $65 million including $0.5 million of underlying EBITDA in the second half of FY20.

    Underlying net profit was $32 million before one-off items. Including those items, the statutory result was a net loss of $8.2 million.

    Management said the business can be profitable on its domestic-only model with a significant contribution from its essential services travel. Its client retention rate is more than 97% and it said it’s winning business in all regions.

    The company saw an underlying EBITDA loss of $2.2 million in July 2020, though the ANZ and European regions broke even.

    There was no interim or final dividend in FY20.

    Nearmap Ltd (ASX: NEA)

    The Nearmap share price fell over 11% today – it was one of the worst performers within the ASX 200 after reporting its FY20 result.

    Its annualised contract value at 30 June 2020 was $106.4 million, up from $90.2 million a year ago. Statutory revenue increased by 25% to $96.7 million. Customer churn increased to 9.9% during the year, up from 5.3%.

    However, it said its EBITDA fell from $15.5 million last year to $9.1 million in FY20.

    It reported a much steeper net loss after tax of $36.7 million after making a number of investments across the business for growth.

    In the first seven weeks of FY21, Nearmap said its ACV portfolio growth has continued. It’s similar to the growth rate for the same period in FY20.

    Domino’s Pizza Enterprises Ltd. (ASX: DMP)

    The Domino’s share price rose by 8.9% today after reporting.

    Network sales rose 12.8% to $3.27 billion and online sales increased by 21.4% to $2.36 billion.

    The ASX 200 busines revealed that its underlying earnings before interest and tax (EBIT) went up by 3.6% to $228.7 million. Underlying net profit after tax rose by 3.3% to $145.8 million. Underlying earnings per share (EPS) rose by 2.7% to 169.4 cents.

    Free cash flow rose 90.6% to $161.8 million and the full year dividend was increased by 3.3% to 119.3 cents.

    The company is aiming for same store sales growth of 3% to 6% per annum over the next three to five years whilst growing its store count by 7% to 9% per annum.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and WiseTech Global. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited and Nearmap Ltd. The Motley Fool Australia has recommended Domino’s Pizza Enterprises Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX 200 rises 0.7%, CSL soars 6.4% appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3kUBIWS

  • Webjet share price on watch after reporting $143.6 million loss

    Corporate travel jet flying into sunset

    Corporate travel jet flying into sunsetCorporate travel jet flying into sunset

    The Webjet Limited (ASX: WEB) share price will be one to watch on Thursday following the release of its FY 2020 results after the market close.

    How did Webjet perform in FY 2020?

    It certainly was a difficult 12 months for the online travel agent due to the COVID-19 pandemic.

    After delivering a record profit result in the first half, the pandemic led to a collapse in booking activity and revenue in the second.

    This ultimately led to Webjet reporting a 27% decline in revenue to $266.1 million. This comprises first half revenue of $217.8 million and second half revenue of $48.3 million.

    Things were unsurprisingly much worse for the company’s earnings before interest, tax, depreciation and amortisation (EBITDA). On a statutory basis, Webjet posted an EBITDA loss of $91.3 million for the year. This was down 171% year on year and comprised positive EBITDA of $46.4 million in the first half and an EBITDA loss of $137.7 million in the second half.

    This statutory result includes one-off items totalling $117.7 million. These include $40 million debtor write-offs, $14.6 million associated with the closure of Webjet Exclusives, and a $20 million impairment of intangibles from the closure of Online Republic Cruise.

    On an underlying basis, which excludes the one-offs, Webjet’s EBITDA fell 80% to $26.4 million. This comprises first half EBITDA of $86.3 million and a second half EBITDA loss of $59.9 million.

    Finally, on the bottom line, Webjet recorded a statutory net loss after tax of $143.6 million and an underlying net loss after tax of $42.3 million.

    Balance sheet.

    Thanks to a combination of its equity raising and notes offering, Webjet finished the period with pro forma cash on hand of $320 million and pro forma liquidity of $420 million.

    All being well, this will give Webjet sufficient liquidity to ride out the current crisis. Especially following its 50% reduction in average monthly operating expenses in comparison to the first half.

    FY 2021 outlook.

    The company notes that after essential worker travel, domestic leisure markets are expected to be the first to open around the world. As a result, it feels all its businesses are well-placed to capture the pick-up in travel activity when it happens.

    Webjet’s managing director, John Guscic, commented: “Whilst it is impossible to predict the timing of market recoveries, travel is recognised as a fundamental driver of global society. Travel is aspirational and exciting and once markets re-open, we expect to see unprecedented airline, hotel and tourism offerings – it will be a time of rediscovering the world.”

    “Our B2C businesses are highly scalable and the strength of the Webjet OTA brand should enable it to thrive as domestic markets open up. Our strategic objective for the WebBeds business is to be the #1 global player and everything we are doing now is focused on ensuring we emerge in a stronger position and giving ourselves the greatest opportunity to achieve that goal,” he added.

    Mr Guscic concluded: “Our global footprint and reduced cost base provides a powerful platform from which we are determined to maximise to the sustainable benefit of our shareholders and stakeholders.”

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Webjet share price on watch after reporting $143.6 million loss appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/32bC96O

  • How will the University of Oxford’s COVID-19 vaccine impact ASX share prices?

    If you’re anxiously awaiting the arrival of a COVID-19 vaccine raise your hand.

    Okay, you can put your hand down now. (I’m assuming it was up!)

    There have been whispers and rumours of an effective vaccine since the earliest weeks of the pandemic. Russia, among other nations, is currently trialling one. We wish them luck.

    But the best hopes of an effective vaccine now look to lie with the University of Oxford.

    Earlier today Prime Minister Scott Morrison announced the government has signed an agreement to secure 25 million doses of a potential COVID-19 vaccine — enough for every Australian — with the UK’s AstraZeneca plc (LON: AZN). If successful it will be free, and mandatory, for all Australians.

    The vaccine was developed by Oxford University and has now entered its third phase. This will see it tested on thousands of volunteers.

    According to Morrison, “The Oxford vaccine is one of the most advanced and promising in the world, and under this deal we have secured early access for every Australian.”

    Rather than purchasing 25 million doses of the vaccine, if it proves successful, Australia will receive the formula and immediately begin to manufacture it domestically.

    How will a successful vaccine impact ASX share prices?

    As with any massive shifts to global economic output and the very way people are living their lives, a successful vaccine is likely to see some ASX share prices post strong gains while others fall.

    One potential winner from the Oxford vaccine is biotech company CSL Limited (ASX: CSL). CSL is in discussion to produce the vaccine in Australia, though the company notes it is still working through various issues.

    CSL’s share price has been on a rollercoaster of a ride this year. So far in August, that ride’s been mostly up hill, with CSL’s share price gaining 16% so far in August, giving it a market cap of $142 billion.

    On a broader scale, other likely big winners are shares involved in the travel and leisure industries.

    Flight Centre Travel Group Ltd (ASX: FLT), for example, has been hammered by the pandemic’s impact on travel. The Flight Centre share price is down 70% year-to-date. Though in a sign that investors are beginning to look beyond the pandemic, Flight Centre shares have gained 12% so far in August.

    The potential downside for ASX share prices

    Some of the shares that could well come under pressure are, not surprisingly, the same shares that have benefitted. That could be particularly concerning for shares that have gained on the back of trillions of dollars in global government and central bank stimulus. Stimulus that will almost certainly begin to wind down following an effective vaccine.

    As quoted by Bloomberg, George Mussalli, head of research and chief investment officer for equities at PanAgora, says, “The risk is a taper tantrum. That’s what everyone is going to be worried about.”

    Yousef Abbasi, global market strategist at StoneX adds:

    The Fed will have to gently and carefully pull back from the policy measures enacted during the pandemic, and it will likely create a period of elevated volatility and indigestion for these markets. That is, of course, unless Chairman Jay Powell is a better magician than his contemporaries.

    It’s a similar story here in Australia, where both the Morrison government and RBA Governor Philip Lowe will need to step carefully when winding back stimulus measures.

    Careful as they may be, though, some share prices will likely suffer.

    JB Hi-Fi Limited (ASX: JBH), for example, has benefitted from some consumers finding more money in their pockets with less places to spend it. And they’ve been snapping up the retailer’s electronics offerings.

    That’s seen the JB Hi-Fi share price gain 33% year-to-date. And JB Hi-Fi’s share price is up an eye-popping 116% since its 25 March low.

    That share price surge was justified when the company’s full year results were released on Monday. JB Hi-Fi reported its profits were up 33.2% due to strong growth in sales.

    But many brokers, including Credit Suisse and UBS, are forecasting JB Hi-Fi’s operating revenue will fall in FY21 as stimulus measures are wound down.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post How will the University of Oxford’s COVID-19 vaccine impact ASX share prices? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31YkYoQ

  • Is it time to break up Big Tech (and our banks)?

    White puzzle pieces being split apart on blue background

    White puzzle pieces being split apart on blue backgroundWhite puzzle pieces being split apart on blue background

    I wrote last week about the impact of the government’s COVID response on the future of the federal budget (and our expectations of those who govern us).

    In short, the government is going to get bigger, both because we have a mammoth debt to service and because we, as a nation, expect our governments to provide increasing levels and breadth of service. And that’s not to mention the growing burden of the aged pension and health budget as our population continues to age!

    But there’s something else that’s been getting big for a while now.

    Companies.

    Australia has long been the land of the duopoly (two dominant players) and oligopoly (a handful of dominant players).

    Actually, when I say it has ‘long been the land of the duopoly’, it’s probably more accurate to say ‘has steadily become the land of the duopoly’. 

    When I was a kid there were many, many competitors in most industries. Now? There are lucky to be more than three serious national players in any of them. To wit:

    We have two national airlines.

    Two major supermarket chains.

    A small handful of service station brands.

    There are three pharmaceutical wholesalers, and only one wholesaler for independent grocery stores.

    And there are four big banks (with profit margins and returns on assets that often dwarf international competitors).

    We have two major newspaper groups, one of which is owned by one of only three commercial television businesses.

    There’s only a handful of radio proprietors.

    Three telcos.

    Now, as an avowed capitalist, I can appreciate the success of these businesses. To be able to be so successful that you get bigger and bigger — buying or killing the competition along the way — is a feat that shouldn’t be ignored.

    But where are we now?

    And how much is too much?

    See, to function properly, capitalism must feature strong, robust competition, where abnormally high profits entice new competition and ensure the market delivers the benefits of that competition.

    Now, here’s where things can get ideological. Those on one side say ‘well, if competition dries up, companies will get lazy and eventually get disrupted by a new competitor’. Those on the other side will point to the ability of large incumbents to squash any potential challengers.

    For example, the effective duopoly of Woolworths Group Ltd (ASX: WOW) and Coles Group Ltd (ASX: COL) wasn’t enough to stop Aldi and Costco from turning up and shaking up the industry. On the flipside, the independent supermarkets are suffering, and would-be international competitor Kaufland actually spent a small fortune establishing a beachhead here, before deciding it was all too hard and scuttling its own plans.

    Which, by the way, is why closed-minded ideology isn’t very useful. If you come to the situation sure that one or the other opinion is unquestionably right, you miss the nuance!

    And yet, as an economy, it seems very clear to me that the number of serious competitors in almost every industry is reducing, sometimes markedly.

    There was a time when Woolies and Coles had less than half of their current market share, and there were multiple independent grocery wholesalers (and supermarket brands) from which to choose.

    I can rattle off maybe half a dozen long-gone financial institutions, which either closed or were merged into larger and larger entities. At least half of those were in the main street of the suburb I grew up in.

    There’s nothing wrong with that, per se. In the ‘creative destruction’ of capitalism, the small, old and slow tend to be usurped by the young, disruptive and better.

    Except, the big, today, seem bigger than ever.

    And competition — judged by the evidence — seems harder and harder to come by.

    It’s not just here, either.

    There are only two mobile phone OS’: iOS from Apple (NASDAQ: AAPL) and Android from Google (I own shares in Google’s parent, Alphabet Inc (NASDAQ: GOOGL)).

    When once America was worried about the dominance of Wal-Mart, that concern looks almost quaint and completely overshadowed by the rise of Amazon.com Inc (NASDAQ: AMZN) (I own shares in that company, too).

    Movie studios are merging. Bookstores, video rental places, and even cinemas are falling victim to one or two behemoth replacements.

    Google Pay and Apple Pay (plus Paypal Holdings Inc (NASDAQ: PYPL)) have designs on global domination of payments.

    Epic Games, maker of the hit new(ish) game, Fortnite, has lashed out at the size of the cut taken by Apple (and Android) whenever anyone pays to buy something inside the game.

    Uber and Lyft are in a two-horse global race to usurp local and national taxi companies.

    Apple and Amazon are locked in a race to be the first company to be worth US$2 trillion. And that’s not investors getting carried away — these guys are cash generating machines.

    Bigger is often better: better products, cheaper prices, more interoperability (imagine if each country had its own computer operating system) and more features. Indeed the only way Netflix can produce some relatively niche content is because it knows it has a global audience to sell to.

    Indeed, it’s hard to argue that, in most cases, the growth of the behemoths has been anything but positive. In general, prices are lower, quality is better and we’re getting more than we could have imagined.

    And yet…

    That’s always been true… until it wasn’t.

    The growth of the US railroads brought huge benefits to much of America. It opened up transportation routes for goods and passengers. It’s a simplification, but much of America’s growth in the late 1800s can be attributed, at least partly, to that boom.

    Similarly, the successful drilling for oil greased the wheels (often literally) of American commerce, providing cheap fuel and making rail and automotive innovation possible (because it could run on economically-priced fuel).

    And the steel industry provided the framework — again literally — for US growth and prosperity.

    Except these three industries came to also have something else in common: they ended up having — and exercising — power that was significantly anticompetitive; raising prices and making demands that laid bare their essential monopoly/oligopoly power.

    So much so that the US government broke up each of those three industries, to make sure they became more competitive.

    I hope you can see the similarities with modern commerce.

    Yes, the gorillas of today are bringing benefits. But are those benefits too costly? Or, more simply, would they cost less if the market had more, hungrier competitors?

    It wasn’t just the 1800s, either.

    In the 1970s, US telco giant AT&T was a monopoly provider of telecommunications services in the US, and it was subsequently split up to improve the competitiveness of its products, services and — importantly — prices.

    Now, I’m no lawyer. Nor am I a judge, regulator or politician.

    But at one point, Woolworths had the highest net profit margin of any supermarket in the world.

    Our banks are some of the most profitable in the world (depending on the measure you use. In one study, they came out as number one). 

    Should we be proud of those numbers? We’re used to politicians wanting us to be the best at everything, but if our banks and supermarkets are more profitable here than elsewhere, who do you reckon is supplying that profit?

    Yep, us.

    And it suggests that those sectors aren’t as competitive as they should be.

    Should Apple be able to arbitrarily take a 30% cut of every dollar that goes through one-half of the app-store duopoly? Should Google?

    30% seems like a lot, doesn’t it? Would that sort of margin be possible if there were more competitors in the sector?

    Should Amazon be able to use data from its retail operation to compete with its own suppliers by introducing cheaper home-brand alternatives as soon as the supplier creates enough demand?

    Those aren’t rhetorical questions. They’re policy questions that deserve serious debate.

    And we, as investors (and consumers), are going to end up with the results of those policies.

    Would Woolies be as profitable if the government made it divest half of its stores (a la AT&T). 

    What happens to Apple and Google if they’re forced to open their App Stores to competition?

    Can our banks continue their dominance, if overseas competitors turn up and start competing hard?

    Do we trade off (potentially) worse search results to protect news organisations here in Australia?

    Maybe those questions never get asked.

    But right now, Google and the Australian Government are at loggerheads over media regulation and fair payment.

    Uber and California are at war, which could see the former stop offering its rideshare services in America’s richest (by GDP) state.

    And plenty of people are calling for the break-up of big tech.

    There are smart, serious, well-meaning people on both sides of all of these debates. Policies are being discussed, which could change the competitive landscape.

    And it’s not anti-business, either. Imagine how many new innovative companies could be unleashed by lower barriers to entry, and less-entrenched incumbents. How much faster innovation might happen, and what flow-on effects there might be for other businesses.

    Indeed, there’s an argument that smaller, broken-up companies could actually perform better than their larger, whole, parents. That’s what happened to AT&T, the breakup of which one author called the ‘Deal of the Century’.

    They’re hard questions to grapple with.

    When does consumer benefit trump supplier cost? (For example, Apple’s ecosystem delivers huge benefits to its users, so maybe the 30% cut of app sales and less competition for app developers is worth it).

    Indeed, what is the reason for competition law? Does the end justify the means?

    Are consumer benefits more important than supplier benefits? Does it matter that there are only two airlines, if flights are cheap enough? Or does that stifle competition for their suppliers?

    These are difficult questions. But they’re being asked, increasingly, among academics, policy wonks, regulators and politicians.

    The answers, if they come, will determine the playing field for companies throughout the 2020s and beyond.

    Investors need to watch closely.

    Fool on!

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Scott Phillips owns shares of Amazon. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Alphabet (A shares), Amazon, Apple, and PayPal Holdings. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Costco Wholesale and recommends the following options: short January 2022 $1940 calls on Amazon, long January 2022 $1920 calls on Amazon, and long January 2022 $75 calls on PayPal Holdings. The Motley Fool Australia owns shares of COLESGROUP DEF SET and Woolworths Limited. The Motley Fool Australia has recommended Alphabet (A shares), Amazon, Apple, and PayPal Holdings. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is it time to break up Big Tech (and our banks)? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3iUsrwd

  • Northern Star share price drops lower despite record profit and special dividend

    Hand holding solid gold bar in front of neutral background

    Hand holding solid gold bar in front of neutral backgroundHand holding solid gold bar in front of neutral background

    The Northern Star Resources Ltd (ASX: NST) share price was out of form on Wednesday despite announcing a record full year profit.

    The gold miner’s shares ended the day 3.5% lower at $14.45.

    How did Northern Star perform in FY 2020?

    For the 12 months ended 30 June 2020, Northern Star delivered a record underlying net profit after tax of $291 million, which was an impressive 69% year on year increase.

    Also growing exceptionally strongly was its underlying free cashflow. It lifted 190% or $277.3 million to $423.1 million during the year.

    This led to the miner ending the period with $769.5 million in cash, bullion and investments. This is despite the company investing $1.3 billion in acquisition and growth opportunities in FY 2020.

    In light of this, the company declared a final fully franked dividend of 9.5 cents per share. This was up 27% on the prior corresponding period and brings its full year dividend to 17 cents per share. The board has also decided to reward shareholders with a special fully franked dividend of 10 cents per share.

    What were the drivers of Northern Star’s strong result?

    Northern Star’s strong result was driven by a 7% increase in gold sold to 900,388 ounces and a 25% lift in average gold price per ounce to $2,208. The latter more than offset a 15% lift in its all-in sustaining cost (AISC) to $1,496 an ounce.

    The good news is that the spot gold price is currently trading notably higher than FY 2020’s average gold price. As a result, management is confident that FY 2021 will be another year of bumper free cashflows. Especially given its production guidance over the 12 months.

    It is forecasting production of 760,000 to 840,000 ounces from its Australian operations and 180,000 to 220,000 ounces from its US-based Pogo operation. The means total production in the range of 940,000 to 1,060,000 ounces in FY 2021. This compares to 984,675 ounces in FY 2020.

    Northern Star’s Executive Chair, Bill Beament, commented: “We are on track to generate further significant increases in cashflow thanks to our substantial leverage to the gold price, our growing production profile and having one of the lowest capital intensity in the industry.”

    “We also have a pipeline of future growth opportunities in and around our other assets and infrastructure, which will help us drive ongoing increases in cashflow while maintaining our superior financial returns,” he added.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Northern Star share price drops lower despite record profit and special dividend appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2YeN9PE

  • The REA Group share price is closing in on its record high

    growth shares

    growth sharesgrowth shares

    The REA Group Limited (ASX: REA) share price is testing the heights again today as the company closes in on its all time high of $119.

    Trading at around $118.65 at the time of writing, REA Group shares are once again surging to levels we saw only 7 days ago.

    The share price fell around 4% on 12 August, following the release of its financial results for FY20. But only a week later, the multinational digital advertising giant is gaining back all lost ground to test previous highs.

    With such strength in the REA Group share price, could this present a buying opportunity?

    About REA Group

    REA Group is a multinational digital advertising business specialising in real estate.

    The company runs realestate.com.au, realcommercial.com.au and flatmates.com.au. Between them, these three websites operate Australia’s top residential, commercial and share property advertising businesses.

    In addition to these well-known brands, the company owns an Australian ‘co-working’ space website called spacely.com.au.

    Overseas, Asian operations in the property space are extensive and stretch across Malaysia, Hong Kong, Indonesia, Singapore, China and Thailand. 

    Not only does the REA Group own and operate this large portfolio, but it also owns significant share portfolios in related companies in the United States and India.

    In 2019, REA Group assumed 100% ownership Australian mortgage broker Smartline Personal Mortgage Advisors. 

    The group had acquired more than 80% of the mortgage broker back in 2017, so a full takeover was always on the cards. This is a strategic acquisition for the group and now allows them to offer even more services to their clients. Its makes sense that a customer looking to buy a house online will likely also need a mortgage broker. 

    Recent Results

    Some high level points from the recent reporting are:

    • Revenue declined by 6% to $820 million
    • Net profit down 9% to $269 million.
    • Media revenue down 19%
    • Financial services revenue down 15%

    Considering the COVID-19 pandemic has drastically restricted the ability to operate in the real estate space, these results really aren’t too bad in the scheme of things.

    REA Group share price performance

    The company’s share price took a serious hit in March this year, falling almost 50%. The COVID-19 pandemic has presented a real challenge for the group.

    However a strong recovery has occurred since then. From a low price in March of around $62, the REA Group share price has rocketed back up to challenge previous highs, trading past $118 today.

    This represents a staggering 90% price increase in less than half a year. 

    For investors interested in long-term performance, the REA Group share price is up more than 7,700% since listing in 1999. A healthy return by any measure.

    Foolish Takeaway

    REA Group is a digital advertising giant. The company has been on the market for more than 20 years and is still going strong. The recent acquisition of a mortgage broking company is a strategic play and creates a situation where it has multiple revenue streams from a single customer.

    If the group can push past its all time high price of $119, we may see the company reach much higher levels in the near future. Considering it has achieved this strong recovery while the pandemic still threatens the economy, I have no doubt REA Group will be stronger than ever on the other side of a vaccine. 

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor glennleese has no position in any of the stocks mentioned. The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post The REA Group share price is closing in on its record high appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3hdP9yT

  • Is this ASX biotech share the next CSL?

    Investor holding tablet and selecting an option with a smiley face to indicate choosing the right shares

    Investor holding tablet and selecting an option with a smiley face to indicate choosing the right sharesInvestor holding tablet and selecting an option with a smiley face to indicate choosing the right shares

    I think that every portfolio should have some exposure to the healthcare industry, including 1 or 2 small-caps that make up less than 5% of the total portfolio’s value. Emerging ASX biotech companies such as Opthea Ltd (ASX: OPT) and Polynovo Ltd (ASX: PNV) could be possible inclusions.

    Mesoblast Limited (ASX: MSB) has been gaining a lot of investor attention over the past few weeks. A raft of announcements regarding the FDA’s position on the company’s hero-drug candidate has led the Mesoblast share price on a wild ride.

    Choosing a medical business that can develop a drug from lab to commercialisation without hiccups is akin to finding the holy grail.

    As healthcare shares can be hit or miss, here is why I believe Mesoblast should be on everyone’s watchlist.

    What does Mesoblast do?

    The biotech company is a world leader in developing regenerative medicines for inflammatory diseases such as advanced heart failure, chronic back pain and graft versus host disease (GvHD).

    Mesoblast has leveraged its cell therapy technology to establish a broad portfolio of commercial products and late-stage product candidates.

    The applications for its products provide an exciting potential pipeline for future sales.

    What’s been fuelling the Mesoblast share price?

    Early last week, a report came through from the US Food and Drug Administration (FDA) raising questions on the effectiveness of Mesoblast’s product candidate remestemcel-L. The Mesoblast share price tanked on the news to hit a low of $2.98 on the day.

    The following morning, the Oncologic Drugs Advisory Committee of the FDA had a meeting and voted 8 to 2 in favour supporting the efficiency of remestemcel-L in children with steroid-refractory acute graft versus the host disease. Indeed a quick turnaround from the FDA’s prior decision.

    The positive announcement saw the Mesoblast share price surge to as much as 57% at one stage, reaching as much as $5.30.

    Yesterday, the Mesoblast share price hit a multi-year high of $5.37, before finishing the day at $5.20 – a gain of 5.91%. Today it has lost a little of those gains, down 1.15% to $5.14 per share.

    The FDA will now decide on the formal approval for remestemcel-L on 30 September.

    Mesoblast’s balance sheet

    In its most recent quarterly activity report, the company advised cash on hand was at US$129.3 million and its total operating activities was US$19.6 million. A capital raise was completed in May this year for US$90 million to institutional investors at $3.20 per share.

    Mesoblast is expected to release its preliminary report on 28 August.

    Foolish takeaway

    Mesoblast has an opportunity for potentially huge revenue should the FDA approve its drug next month. The company has plans to launch in the United States to capture the world’s largest healthcare market.

    I think that the Mesoblast share price will stabilise in the near-term pending its prelim results and the outcome of its remestemcel-L drug from the FDA. It would be best to wait on the side lines for now and add Mesoblast to your watchlist.

    Looking Mesoblast’s market capitalisation (at the time of writing) of $3 billion, I would say it’s fairly valued.

    I will be keeping a close eye on the Mesoblast share price over the next few weeks before making an investment decision.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Aaron Teboneras owns shares of CSL Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is this ASX biotech share the next CSL? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2CFZXqt

  • I think the A2 Milk share price is a buy

    A2M share price

    A2M share priceA2M share price

    I believe that the A2 Milk Company Ltd (ASX: A2M) share price is a buy after the infant formula company reported its FY20 result.

    The highlights

    There were a number of impressive financial numbers reported by the company.

    Total revenue increased by 32.8% to NZ$1.73 billion. Earnings before interest, tax, depreciation and amortisation (EBITDA) increased by 32.9% to NZ$549.7 million.

    Net profit after tax (NPAT) rose by 34.1% to NZ$385.8 million with operating cash flow of $427.4 million.

    The business finished with a closing cash balance of NZ$854.2 million.

    Segment growth

    Infant nutrition revenue rose by 33.8% to NZ$1.42 billion, which is impressive considering this came after years of strong growth.

    Liquid sales revenue across the business rose by 29.7% to NZ$222 million.

    One of the main reasons I think that the A2 Milk share price is a buy is due to the international growth potential.

    Chinese label infant nutrition sales more than doubled to NZ$337.7 million and the distribution was expanded to 19,100 stores. The China label infant formula brand now accounts for 24% of the total infant formula business.

    In October the company launched a new Hong Kong label range of infant formula and in December it launched stage 1 to stage 3 infant formula in South Korea with its partner YuhanCARE. In March A2 Milk entered into a licensing agreement with AgriFoods in Canada to produce, market and distribute the A2 Milk fresh milk brand. These are promising moves. 

    A2 Milk is growing strongly in the US with revenue growth of 91.2% to $66.1 million. Distribution has now reached 20,300 stores, up from 17,500 stores at the end of December 2019. Interestingly, the company said the economic environment has led the company to reduce its focus on broadcast advertising and emphasise the in-store price and activation to drive demand. It’s expecting an improved EBITDA result here for FY21.

    Guidance

    The company said there continues to be uncertainty due to COVID-19, but overall in FY21 it’s expecting “continued strong revenue growth” supported by continuing investments in marketing and operational capability.

    It’s expecting the FY21 EBITDA margin to be between 30% to 31% due to higher raw material and packaging costs (partly offset by price increases), more marketing spending, foreign currency and pantry stocking benefits unlikely to be repeated. Over the longer-term A2 Milk is still aiming for a 30% EBITDA margin – I think that strikes the right balance of profitability and investing for growth.

    The A2 Milk share price fell heavily during the second half of 2019 when the company was guiding that its EBITDA margin would decline due to investing more for growth. 

    Growing balance sheet

    I thought the comments on its capital allocation were particularly interesting. A2 Milk said that due to the growing scale of its business, it considers it appropriate to assess participation in its manufacturing capacity and capability to complement its existing supply chain relationships. The company is evaluating the options.

    There is potential for returns to shareholders after the company said it was reviewing its capital requirements for the future. It needs to keep enough capital to remain robust, but I think A2 Milk could (and should) start to reward shareholders with a reasonable dividend, or perhaps share buybacks if it’s at a good share price to do so. It may soon have NZ$1 billion of cash on the balance sheet to decide what to do with.

    At this share price I think A2 Milk is a buy

    At the time of writing the A2 Milk share price is down around 5%. But that’s just today’s reaction. Since the start of 2020 the A2 Milk share price has risen by 32%.

    The company has enormous international growth potential. It’s early days in the US and it’s only just getting started in Canada. There are legitimate China worries, but don’t forget that A2 Milk is a New Zealand company, not an Australian one.

    It’s currently trading at 28x FY22’s estimated earnings. I think that seems much more reasonable than many other growth shares that are trading much more expensively, even though the profit growth rates aren’t that different. I’d be happy to buy A2 Milk shares for the long-term today. 

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post I think the A2 Milk share price is a buy appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3iSJX3R